Authors
Loading...
Findings demonstrate UBE2T's role in promoting ECM deposition in PDAC, suggesting targeting UBE2T may improve immunotherapy efficacy.
Ma et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: